基本信息
浏览量:303
职业迁徙
个人简介
For more than 30 years, Dr. Fox has directed his research efforts at improving the effectiveness of cancer immunotherapy. An expert in tumor immunology and immune profiling, he leads the Laboratory of Molecular and Tumor Immunology and provides oversight for the Biospecimen Repository, a core facility available to all investigators of the Earle A. Chiles Research Institute. Additionally, he is an associate professor in Molecular Microbiology and Immunology at Oregon Health and Science University, and is a co-leader of the Tumor Immunology Focus Panel for the Knight Cancer Institute.
Dr. Fox’s background in translational cancer immunotherapy developed from his tenure as a fellow in Dr. Steven Rosenberg’s lab at the National Cancer Institute, a part of the National Institutes for Health. His research efforts are divided between preclinical models, the development, performance, and monitoring of cancer immunotherapy trials, and the training of the next generation of translational investigators. He has served on review committees for the NIH, FDA, philanthropic and governmental organizations in the United States, Europe and Asia. He serves on editorial boards of seven scientific journals, lectures widely, consults for the biotechnology and pharmaceutical sectors, and is an internationally recognized expert on cancer immunotherapy.
Dr. Fox is past president of the Society for Immunotherapy of Cancer and is current chair of the World Immunotherapy Council, a consortium of 22 national and international cancer immunotherapy organizations. He also serves on the Board of Directors of the Oregon Bioscience Association.
Memberships
American Association for Advancement of Science
American Association for Cancer Research
American Association of Immunologists
American Society of Clinical Oncology
Society for Immunotherapy of Cancer
Honors and Awards
Extraordinary Service to Society Award, Society for Immunotherapy of Cancer (SITC), 2020
Member, SITC COVID-19 Response Task Force, 2020-present
Member, Cellular, Tissue, and Gene Therapies Advisory Committee, US FDA, 2020-present
Chair, Scientific Advisory Board, Marseille Immunopole, French National Science
Agency/European Union NSCLC Immunotherapy Program, 2019-2024
Council Member, American Cancer Society, 2015-2018
Board of Directors, Oregon Bioscience Association, 2014-present
External Advisory Board, Karmanos Cancer Institute, Wayne State University, Detroit, MI, 2014-2016
Section Editor, Journal for Immunotherapy of Cancer, SITC official Journal, 2013-2016
Scientific Advisory Board, McMasters Immunology Research Centre, Hamilton, Ontario, 2012-2015
Chair, SITC Global Colon Cancer Immunoscore Taskforce / Steering Committee, 2012-present
Chair, World Immunotherapy Council (WIC), 2011-present
Editorial Board, OncoImmunology and International Journal of Oncology, 2011-present
Executive Council, Society for Immunotherapy of Cancer (SITC), 2010-present
External Advisory Board, Vaccine Branch, Center for Cancer Research, NCI, NIH, 2009-present
Editorial Board, Tumor Immunology and Biological Cancer Therapy, iSBTc/SITC section of the Journal of Translational Medicine, 2009-present
External Scientific Advisory Board, Hollings Cancer Center, Medical University of S.C., 2009-2013
President, SITC, 2008-2010
Vice President/President Elect, SITC, 2006-2008
Treasurer, SITC, 2005-2006
Co-founder and Managing Member/CEO, UbiVac, 2005-present
Member, Cancer Immunopathology and Immunotherapy (CII) Study Section NCI, NIH, 2003-2005
Editorial Board, Journal of Immunotherapy, 2003-present
Board of Directors, International Society for the Biological Therapy of Cancer (iSBTc), 2002-2005
Member, Experimental Therapeutics II (ETII) Study Section NCI, NIH, 2002-2003
Guest Professor, Xi’an Jiaotong University, Xi’an, China, 2001-2010
Editorial Board, Expert Opinion on Biological Therapy, 2001-present
Visiting Professor Award, Chiles Foundation, 2001 – 2002
Guest Professor Award, Der Deutsche Akademische Austausch Dienst, 2001 – 2002
Editorial Board – Cellular Immunology and Current Molecular Medicine, 2000-present
Science Recognition Award for New Investigators, Clinical Immunology Society,1990
Travel Grant, 7th Int’l Immunology Congress, American Association of Immunology, 1989
Dr. Fox’s background in translational cancer immunotherapy developed from his tenure as a fellow in Dr. Steven Rosenberg’s lab at the National Cancer Institute, a part of the National Institutes for Health. His research efforts are divided between preclinical models, the development, performance, and monitoring of cancer immunotherapy trials, and the training of the next generation of translational investigators. He has served on review committees for the NIH, FDA, philanthropic and governmental organizations in the United States, Europe and Asia. He serves on editorial boards of seven scientific journals, lectures widely, consults for the biotechnology and pharmaceutical sectors, and is an internationally recognized expert on cancer immunotherapy.
Dr. Fox is past president of the Society for Immunotherapy of Cancer and is current chair of the World Immunotherapy Council, a consortium of 22 national and international cancer immunotherapy organizations. He also serves on the Board of Directors of the Oregon Bioscience Association.
Memberships
American Association for Advancement of Science
American Association for Cancer Research
American Association of Immunologists
American Society of Clinical Oncology
Society for Immunotherapy of Cancer
Honors and Awards
Extraordinary Service to Society Award, Society for Immunotherapy of Cancer (SITC), 2020
Member, SITC COVID-19 Response Task Force, 2020-present
Member, Cellular, Tissue, and Gene Therapies Advisory Committee, US FDA, 2020-present
Chair, Scientific Advisory Board, Marseille Immunopole, French National Science
Agency/European Union NSCLC Immunotherapy Program, 2019-2024
Council Member, American Cancer Society, 2015-2018
Board of Directors, Oregon Bioscience Association, 2014-present
External Advisory Board, Karmanos Cancer Institute, Wayne State University, Detroit, MI, 2014-2016
Section Editor, Journal for Immunotherapy of Cancer, SITC official Journal, 2013-2016
Scientific Advisory Board, McMasters Immunology Research Centre, Hamilton, Ontario, 2012-2015
Chair, SITC Global Colon Cancer Immunoscore Taskforce / Steering Committee, 2012-present
Chair, World Immunotherapy Council (WIC), 2011-present
Editorial Board, OncoImmunology and International Journal of Oncology, 2011-present
Executive Council, Society for Immunotherapy of Cancer (SITC), 2010-present
External Advisory Board, Vaccine Branch, Center for Cancer Research, NCI, NIH, 2009-present
Editorial Board, Tumor Immunology and Biological Cancer Therapy, iSBTc/SITC section of the Journal of Translational Medicine, 2009-present
External Scientific Advisory Board, Hollings Cancer Center, Medical University of S.C., 2009-2013
President, SITC, 2008-2010
Vice President/President Elect, SITC, 2006-2008
Treasurer, SITC, 2005-2006
Co-founder and Managing Member/CEO, UbiVac, 2005-present
Member, Cancer Immunopathology and Immunotherapy (CII) Study Section NCI, NIH, 2003-2005
Editorial Board, Journal of Immunotherapy, 2003-present
Board of Directors, International Society for the Biological Therapy of Cancer (iSBTc), 2002-2005
Member, Experimental Therapeutics II (ETII) Study Section NCI, NIH, 2002-2003
Guest Professor, Xi’an Jiaotong University, Xi’an, China, 2001-2010
Editorial Board, Expert Opinion on Biological Therapy, 2001-present
Visiting Professor Award, Chiles Foundation, 2001 – 2002
Guest Professor Award, Der Deutsche Akademische Austausch Dienst, 2001 – 2002
Editorial Board – Cellular Immunology and Current Molecular Medicine, 2000-present
Science Recognition Award for New Investigators, Clinical Immunology Society,1990
Travel Grant, 7th Int’l Immunology Congress, American Association of Immunology, 1989
研究兴趣
论文共 458 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Anna Maria Di Giacomo,Michael Lahn, Alexander MM Eggermont,Bernard Fox,Ramy Ibrahim,Padmanee Sharma,James P. Allison,Michele Maio
European Journal of Cancer (2024): 113501-113501
David A Knorr, Lucas Blanchard,Rom S Leidner,Shawn M Jensen,Ryan Meng,Andrew Jones,Carmen Ballesteros-Merino, Richard B Bell, Maria Baez, Alessandra Marino,David Sprott,Carlo B Bifulco,
Cancer immunology researchno. 3 (2024): 322-333
Brendan D. Curti,Magdalena Kovacsovics-Bankowski,Nicholas Morris,Edwin Walker,Lana Chisholm, Kevin Floyd,Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen,Bernard A. Fox,Tarsem Moudgil,William Miller,
crossref(2023)
biorxiv(2023)
crossref(2023)
crossref(2023)
Gloria Lee, Raul Calvo,Karl Kevala,Mark Henderson,Hee-Yong Kim,Juan Marugan,Bernard Fox,Stanley Cohan
MULTIPLE SCLEROSIS JOURNAL (2023): 801-802
引用0浏览0引用
0
0
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
引用0浏览0引用
0
0
Marcus A. Couey,Matthew Taylor,Tarsem Moudgil,Yoshinobu Koguchi, Anne Stadum, Tanisha Christie,William L. Redmond,Christopher Paustian,Ryan Meng,Venkatesh Rajamanickam,Lessli Rushforth, Abigail Peterson,
CANCER RESEARCHno. 8 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn